This one-hour, journal article-based activity examines the efficacy and safety of methylphenidate (MPH) for the treatment of cocaine use disorder (CUD). Learners will explore findings from a systematic review and meta-analysis evaluating the effects of MPH on cocaine craving and use, including differences in outcomes among individuals with and without co-occurring attention-deficit/hyperactivity disorder (ADHD). The article also examines factors that may influence treatment outcomes, considerations related to the safety of MPH, and limitations in the current evidence base to inform future research and clinical practice.

This one-hour, journal article-based activity examines the efficacy and safety of pharmacological interventions for electronic cigarette cessation. Learners will explore current evidence for varenicline, nicotine replacement therapy (NRT), and cytisine, including their effects on abstinence and reported adverse events. The article also examines current limitations in the evidence base and considerations for applying pharmacological approaches to support adults seeking to stop using electronic cigarettes.

This 60-minute, on-demand session from the ASAM 2026 Review Course provides an understanding of key principles such as tolerance, dependence, hyperalgesia, pharmacokinetics, and pharmacodynamics while also discussing applications and limitations including interpretation pitfalls of screening and confirmatory urine drug tests.

This 35-minute, on-demand session from the ASAM 2026 Review Course covers a diverse group of substances including hallucinogens, dissociatives, inhalants, and steroids as well as the physiological effects, epidemiology, and treatment options.

This 88-hour on-demand conference includes 75 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses gas station accessible substances including tianeptine, phenibut, and alkyl nitrites, covering toxidromes, complications, and harm reduction strategies.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses alcohol use disorder treatment in patients with liver disease, including pharmacotherapy safety, transplant considerations, and integrated care models.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses buprenorphine initiation considerations for intubated ICU patients with OUD, including ethical principles, patient selection, and treatment protocols.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses performance and image enhancing drug misuse, exploring health risks, psychosocial factors, and evidence-based screening and management strategies.

This 90-minute on-demand session from the ASAM 57th Annual Conference addresses multisociety consensus guidelines for managing opioid-related complications in chronic pain, including OUD, physiologic dependence, and functional impairment.